Filters
Other countries
Results: 1 to 14 of 14
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
ACTL6B - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Genetic Services Laboratory University of Chicago United States | 47 | 125 |
|
Epilepsy - Intellectual Disability - Autism Spectrum Disorder Amplexa Genetics Amplexa Genetics A/S Denmark | 1 | 600 |
|
Early Infantile Epileptic Encephalopathy Panel Genetic Services Laboratory University of Chicago United States | 47 | 125 |
|
CGC Genetics Unilabs Portugal | 1 | 832 |
|
Neurodevelopmental and Movement Disorders Panel Mendelics Brazil | 2 | 121 |
|
Developmental and epileptic encephalopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 88 | 86 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
GeneDx United States | 2 | 2592 |
|
GeneDx United States | 1 | 1501 |
|
Asper Biogene Asper Biogene LLC Estonia | 210 | 204 |
|
Fulgent Genetics United States | 1 | 1 |
|
Results: 1 to 14 of 14
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.